Join our newsletter to stay up to date on cases and settlements.
Have you used Zantac and developed Liver Cancer, Stomach/Gastric Cancer, Esophageal Cancer, Pancreatic Cancer, Bladder Cancer, and Intestinal Cancer? You may qualify for compensation, learn more today!
Last Update
A Maryland resident has filed a lawsuit in Delaware Superior Court against multiple pharmaceutical companies, including Boehringer Ingelheim, Sanofi, and Patheon Manufacturing Services, alleging that Zantac (ranitidine) exposure caused his prostate cancer. The plaintiff consumed both prescription and over-the-counter Zantac between 2019 and 2020, unknowingly ingesting NDMA. The complaint cites scientific evidence linking NDMA to cancer and alleges that defendants concealed the risks despite knowing that ranitidine could degrade into NDMA under certain conditions. The lawsuit asserts claims for defective design, failure to warn, negligence, and breach of warranty, seeking compensatory and punitive damages for the alleged harm.
A shareholder lawsuit has been filed against GSK in Pennsylvania federal court, alleging the company concealed Zantac’s cancer risks for nearly 40 years, misleading investors and causing stock losses. Brought by Roofers Local No. 149 Pension Fund, the complaint claims GSK knew as early as 1982 that Zantac contained high levels of NDMA, a carcinogen, but failed to disclose this information. Investors were allegedly misled by public assurances denying a cancer link despite internal data suggesting otherwise. These allegations align with claims in ongoing personal injury and wrongful death lawsuits related to Zantac.
An Illinois jury has ruled in favor of Boehringer Ingelheim, rejecting claims that long-term Zantac use contributed to prostate cancer diagnoses. The verdict was reached after just two hours of deliberation in a four-week retrial, following hung juries in previous proceedings. Other Illinois juries have also dismissed similar claims in recent trials. While some Zantac-related cancer claims remain stronger—such as those involving bladder, esophageal, and stomach cancer—this latest defense verdict represents a setback for plaintiffs. Future trials will be critical in determining the strength of remaining claims and whether plaintiffs can build momentum in the litigation.
In the ongoing Zantac retrial, the defense claims no studies link the drug to prostate cancer, while plaintiffs argue the research cited is based on unrealistic dosing scenarios. Cross-examination revealed that manufacturers did not test for NDMA contamination before 2019, despite knowing the drug degraded over time. The FDA recalled Zantac in 2020, but plaintiffs contend this action was too late. Previous juries have deadlocked in prostate cancer cases, making this retrial a key test for plaintiffs, though these claims face greater challenges compared to other Zantac-related lawsuits.
For heartburn sufferers, Zantac seemed a blessing because of its effectiveness. However, in recent years, the once-popular heartburn medication has been linked to serious health risks.
For years, millions of people trusted Zantac to relieve their acid reflux and heartburn. Unfortunately, recent discoveries have shown that Zantac and other ranitidine products could contain dangerous levels of a cancer-causing chemical called NDMA. Without a doubt, the news is alarming because many people have used Zantac daily for years without ever realizing they were putting their health at risk.
Studies have revealed that NDMA in Zantac has a link to certain types of cancers, including stomach, liver, bladder, and pancreas.
Have you or a loved one recently developed a cancer that you believe is related to the long-term use of Zantac? If so, you are not alone, and you do have legal options, such as joining a class action lawsuit to seek compensation.
Have you or a loved one used Zantac? If so, you may be eligible to participate in a Zantac class action lawsuit.
Do you meet the following criteria?
You may also qualify if you've been diagnosed with the following cancer(s).
Please note: You must have been diagnosed January 1st, 2000 - current year to potentially qualify. In addition, you must be a non-smoker and have used Zantac for a minimum of one year.
If you meet the above requirements, you may be entitled to compensation. We encourage you to seek legal advice to determine your eligibility. Various factors impact eligibility and all cases are unique.
Participating in a Zantac class action lawsuit could help you obtain monetary compensation to pay for your medical bills, pain, and suffering.
The makers of Zantac, including major pharmaceutical companies, are facing lawsuits. These companies are accused of failing to warn consumers about the risks of NDMA contamination in their products. Even after learning the risks of NDMA, the companies continued to market and sell Zantac even after the potential dangers became widely known.
As more information emerges, it is believed that the number of cases against these companies will grow by leaps and bounds. If you or someone you care about has been impacted by Zantac use, then you may have a case.
The amount of compensation you might receive depends on a variety of factors, such as:
Currently, Zantac lawsuits remain in their infancy, and no major settlements have been reached. However, based on similar cases, compensation could be significant, especially for those who have suffered the most.
Has your health been impacted by Zantac use? If yes, do not hesitate. Reach out today to learn if you may qualify to participate in a Zantac lawsuit.
This is an advertisement. OnlyClassActions is not a law firm or referral service, and we do not provide legal advice. OnlyClassActions provides a free service for individuals seeking legal representation, and we do not charge you to be connected with an attorney. We do not recommend or endorse any attorneys that pay to participate. OnlyClassActions utilizes a pool of attorneys in each jurisdiction, and attorneys are selected through a round-robin process without our evaluating your legal situation when selecting which attorney will receive your information. OnlyClassActions makes no representation about the quality of legal services or the qualifications of any attorney participating in our pool. Information you submit will be shared with third-party attorney(s). An attorney-client relationship is not formed when you submit information through the form. Hiring a lawyer is a critical decision and should not be predicated solely on comments, advertisements, or other content found on any website. You are under no obligation to retain a lawyer who contacts you through this service.
Add Comment